c-MET inhibitor SU11274, Purity ≥98%

Synonym: 658084-23-2; c-MET inhibitor; SU-11274; PKI-SU11274

MDL: MFCD08276928
CAS Number: 658084-23-2
Compound CID: 9549297

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

SU11274, soluble in DMSO and ethanol and insoluble in water, inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets Flk1, RON, CDK2, EGFR, FGFR1, MET, and PDGFRβ.

Molecular Weight

568.1

Molecular Formula

C₂₈H₃₀CIN₅O₄S

Targets

Flk-1: 1.25 μM; RON: 4.0 μM; CDK2: >10 μM; EGFR: >100 μM; FGFR1: 8.5 μM; MET: 0.01 μM; PDGFRβ: >20 μM

Form

Lyophilized powder

Purity

Solubility

DMSO: 83 mg/mL (146.1 mM); Water: Insoluble; Ethanol: 2 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

SU11274 is a c-MET inhibitor, providing research insights into the modulation of oncogenic signaling cascades.